Elpro International Ltd

📈 Elpro International Boosts Stake in Cohance Lifesciences

• Acquired 133,086 equity shares of Cohance Lifesciences for ₹4.79 Crores

• Total holding now stands at 248,813 equity shares (up from 115,727)

• Cohance operates in pharmaceutical sector with presence in India and United States

• Reported consolidated revenue of ₹1,197.58 Crores and total income of ₹1,256.14 Crores in FY 2024-25

• Acquisition was for investment purposes with no governmental approvals required

• Company was incorporated on November 6, 2018 and has grown through multiple acquisitions